Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1581

Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.
North America has the huge number of population suffering from cancer, according to National Cancer Institute which come under the U.S health, the statistic published in 2016 around 1,685,210 new cancer is diagnosed and 595,690 people died due to cancer. Cancer is the second important cause of death in Europe as per the WHO Regional Office for Europe in 2012, around 3.7 million new cases of cancer occur in Europe and 1.9 million death each year. Same as for Asia Pacific and the creating the awareness is also the necessary aspect to be consider.
In 2018, the global Non-Hematological Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Non-Hematological Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Hematological Cancer Treatment development in United States, Europe and China.

The key players covered in this study
Novartis
Pfizer
Bristol-Myers Squibb
Johnson & Johnson
Roche
Amgen
Astellas Pharma
...

Market segment by Type, the product can be split into
Chemotherapy
Surgery
Radiation Therapy
Others

Market segment by Application, split into
Hospitals
Oncology Treatment Centre
Ambulatory Surgery Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-Hematological Cancer Treatment status, future forecast, growth opportunity, key market and key players.
To present the Non-Hematological Cancer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-Hematological Cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-Hematological Cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Surgery
1.4.4 Radiation Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Non-Hematological Cancer Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Oncology Treatment Centre
1.5.4 Ambulatory Surgery Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Non-Hematological Cancer Treatment Market Size
2.2 Non-Hematological Cancer Treatment Growth Trends by Regions
2.2.1 Non-Hematological Cancer Treatment Market Size by Regions (2014-2025)
2.2.2 Non-Hematological Cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Non-Hematological Cancer Treatment Market Size by Manufacturers
3.1.1 Global Non-Hematological Cancer Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Non-Hematological Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Non-Hematological Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Non-Hematological Cancer Treatment Key Players Head office and Area Served
3.3 Key Players Non-Hematological Cancer Treatment Product/Solution/Service
3.4 Date of Enter into Non-Hematological Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Non-Hematological Cancer Treatment Market Size by Type (2014-2019)
4.2 Global Non-Hematological Cancer Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Non-Hematological Cancer Treatment Market Size (2014-2019)
5.2 Non-Hematological Cancer Treatment Key Players in United States
5.3 United States Non-Hematological Cancer Treatment Market Size by Type
5.4 United States Non-Hematological Cancer Treatment Market Size by Application

6 Europe
6.1 Europe Non-Hematological Cancer Treatment Market Size (2014-2019)
6.2 Non-Hematological Cancer Treatment Key Players in Europe
6.3 Europe Non-Hematological Cancer Treatment Market Size by Type
6.4 Europe Non-Hematological Cancer Treatment Market Size by Application

7 China
7.1 China Non-Hematological Cancer Treatment Market Size (2014-2019)
7.2 Non-Hematological Cancer Treatment Key Players in China
7.3 China Non-Hematological Cancer Treatment Market Size by Type
7.4 China Non-Hematological Cancer Treatment Market Size by Application

8 Japan
8.1 Japan Non-Hematological Cancer Treatment Market Size (2014-2019)
8.2 Non-Hematological Cancer Treatment Key Players in Japan
8.3 Japan Non-Hematological Cancer Treatment Market Size by Type
8.4 Japan Non-Hematological Cancer Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Non-Hematological Cancer Treatment Market Size (2014-2019)
9.2 Non-Hematological Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Non-Hematological Cancer Treatment Market Size by Type
9.4 Southeast Asia Non-Hematological Cancer Treatment Market Size by Application

10 India
10.1 India Non-Hematological Cancer Treatment Market Size (2014-2019)
10.2 Non-Hematological Cancer Treatment Key Players in India
10.3 India Non-Hematological Cancer Treatment Market Size by Type
10.4 India Non-Hematological Cancer Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Non-Hematological Cancer Treatment Market Size (2014-2019)
11.2 Non-Hematological Cancer Treatment Key Players in Central & South America
11.3 Central & South America Non-Hematological Cancer Treatment Market Size by Type
11.4 Central & South America Non-Hematological Cancer Treatment Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-Hematological Cancer Treatment Introduction
12.1.4 Novartis Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-Hematological Cancer Treatment Introduction
12.2.4 Pfizer Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-Hematological Cancer Treatment Introduction
12.3.4 Bristol-Myers Squibb Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-Hematological Cancer Treatment Introduction
12.4.4 Johnson & Johnson Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-Hematological Cancer Treatment Introduction
12.5.4 Roche Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-Hematological Cancer Treatment Introduction
12.6.4 Amgen Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Astellas Pharma
12.7.1 Astellas Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-Hematological Cancer Treatment Introduction
12.7.4 Astellas Pharma Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.7.5 Astellas Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details